Ginger Gregory Biogen Inc. (BIIB) insider trading activity

BIIB Quotes by TradingView

Ginger Gregory is EVP, Human Resources of BIOGEN INC.. Currently has a direct ownership of 13,583 shares of BIIB, which is worth approximately $2.36 Million. The most recent transaction as insider was on Feb 16, 2024, when has been sold 2,264 shares (Common Stock) at a price of $219.08 per share, resulting in proceeds of $495,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.6K
0% 3M change
60.14% 12M change
Total Value Held $2.36 Million

Ginger Gregory Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2024
SELL
Payment of exercise price or tax liability
$495,997 $219.08 p/Share
2,264 Reduced 14.29%
13,583 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
-
4,704 Added 24.74%
14,312 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$152,781 $240.98 p/Share
634 Reduced 5.38%
11,143 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
-
2,158 Added 15.49%
11,777 Common Stock
Feb 08 2024
SELL
Payment of exercise price or tax liability
$119,669 $240.3 p/Share
498 Reduced 4.92%
9,619 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
-
1,635 Added 13.91%
10,117 Common Stock
Apr 28 2023
SELL
Open market or private sale
$804,300 $300.0 p/Share
2,681 Reduced 24.02%
8,482 Common Stock
Feb 17 2023
SELL
Payment of exercise price or tax liability
$241,355 $278.38 p/Share
867 Reduced 8.54%
9,280 Common Stock
Feb 17 2023
BUY
Exercise of conversion of derivative security
-
1,792 Added 13.93%
11,072 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$946,507 $286.3 p/Share
3,306 Reduced 24.57%
10,147 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
3,290 Added 20.44%
12,805 Common Stock
Jan 25 2023
BUY
Grant, award, or other acquisition
-
4,452 Added 30.46%
10,163 Common Stock
Nov 14 2022
SELL
Open market or private sale
$1,683,617 $300.11 p/Share
5,610 Reduced 49.55%
5,711 Common Stock
Feb 18 2022
SELL
Payment of exercise price or tax liability
$129,231 $209.79 p/Share
616 Reduced 5.21%
11,218 Common Stock
Feb 18 2022
BUY
Exercise of conversion of derivative security
-
1,387 Added 10.49%
11,834 Common Stock
Feb 12 2022
SELL
Payment of exercise price or tax liability
$268,667 $214.59 p/Share
1,252 Reduced 10.7%
10,447 Common Stock
Feb 12 2022
BUY
Exercise of conversion of derivative security
-
1,672 Added 12.77%
11,421 Common Stock
Jan 19 2022
BUY
Grant, award, or other acquisition
-
1,941 Added 16.22%
10,027 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$606,661 $278.03 p/Share
2,182 Reduced 21.45%
7,990 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
-
2,923 Added 23.94%
9,288 Common Stock
Jan 27 2021
BUY
Grant, award, or other acquisition
-
2,558 Added 26.08%
7,249 Common Stock
GG

Ginger Gregory

EVP, Human Resources
Cambridge, MA

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BIIB